Dynamics Special Purpose Corp. (DYNS): Price and Financial Metrics


Dynamics Special Purpose Corp. (DYNS): $9.94

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

DYNS Stock Price Chart Interactive Chart >

Price chart for DYNS

DYNS Price/Volume Stats

Current price $9.94 52-week high $10.54
Prev. close $9.94 52-week low $9.58
Day low $9.94 Volume 24,500
Day high $9.95 Avg. volume 62,043
50-day MA $9.91 Dividend yield N/A
200-day MA $9.91 Market Cap 235.73M

Dynamics Special Purpose Corp. (DYNS) Company Bio


Dynamics Special Purpose Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2021 and is based in Redwood City, California.


DYNS Latest News Stream


Event/Time News Detail
Loading, please wait...

DYNS Latest Social Stream


Loading social stream, please wait...

View Full DYNS Social Stream

Latest DYNS News From Around the Web

Below are the latest news stories about Dynamics Special Purpose Corp that investors may wish to consider to help them evaluate DYNS as an investment opportunity.

Senti Bio to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (“Senti Bio”), a leading Gene Circuit company today announced that Tim Lu, MD, PhD, Chief Executive Officer and Co-Founder, will present a corporate overview at the 40th Annual J.P. Morgan Virtual Healthcare Conference on Tuesday, January 11, 2022 at 2:00 p.m. EST. Senti Bio uses its Gene Circuit platform to program cell and gene therapies with potentially enhanced capabilities. Gene Circuits, which are create

Yahoo | January 6, 2022

Peninsula 'gene circuits' company taking blank-check route to go public

Initially targeting cancers, Senti believes cells and genes can be engineered to be triggered like computer circuits to perform specific, unique tasks.

Yahoo | December 20, 2021

Senti Bio and Dynamics Special Purpose Corp. Announce Business Combination Agreement to Create Publicly Listed Company Pioneering Gene Circuit-Engineered Cell and Gene Therapies

- Business combination with Dynamics Special Purpose Corp. (Nasdaq: DYNS) is expected to provide more than $296 million in gross proceeds, over $153 million of which is fully committed in a common stock Private Investment in Public Equity (“PIPE”) financing and from non-redemption agreements - - Over $86 million in non-redemption agreements committed from existing Dynamics investors including funds managed by ARK Investment Management LLC, funds and accounts managed by Counterpoint Global (Morga

Yahoo | December 20, 2021

Former Illumina execs, Grail co-founder raise $21M for biotech startup

Illumina Inc.'s ex-chief technology officer and former colleagues raised $21 million for a startup biotech company that, according to a job posting, is seeking engineers and scientists "with a passion to develop the next generation of technologies for unraveling complexities of biology beyond what is within the realm of possibility today.

Yahoo | December 8, 2021

Citadel Advisors LLC Makes New Investment in Dynamics Special Purpose Corp. (NASDAQ:DYNS)

Citadel Advisors LLC bought a new position in Dynamics Special Purpose Corp. (NASDAQ:DYNS) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 180,403 shares of the companys stock, valued at approximately $1,793,000. Citadel Advisors LLC owned 0.76% of Dynamics Special Purpose at the end []

Dakota Financial News | December 6, 2021

Read More 'DYNS' Stories Here

DYNS Price Returns

1-mo 0.40%
3-mo 0.40%
6-mo 0.10%
1-year -0.60%
3-year N/A
5-year N/A
YTD 0.81%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5984 seconds.